| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/20/2006 | WO2005093431A3 Methods for detecting calcium ion influx |
| 04/20/2006 | US20060084164 Bacteria, yeasts or filamentous fungi, producing a fusion protein containing a hydrophobin fused to a protein, an enzyme or part of an enzyme with enzymatic activity, wherein said hydrophobin or hydrophobin-like protein has an ability to partition in aqueous two-phase systems (ATPS) |
| 04/20/2006 | DE102004050101A1 Recombined polypeptide antibody or antibody fragment binds the ED-B domain of Fibronectin |
| 04/19/2006 | EP1647596A2 Monoclonal antibody against platelet membrane glycoprotein vi |
| 04/19/2006 | EP1121381B1 Zinc finger binding domains for gnn |
| 04/19/2006 | EP0812352B1 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
| 04/19/2006 | EP0776370B1 Human erythropoietin receptor fragment and antibodies thereto |
| 04/19/2006 | CN1761684A Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 04/19/2006 | CN1760210A Fusion protein possessing function of weight reduction, coded gene and application |
| 04/19/2006 | CN1760209A Interfusion protein of human interleukin 15 and Fe |
| 04/19/2006 | CN1760208A Iluman wild type P53 fusion protein |
| 04/19/2006 | CN1252087C Tetramer combined with SARS antigen peptide and its preparation and use |
| 04/18/2006 | US7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7029878 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 04/18/2006 | US7029864 Antibody against cleavage product of vimentin |
| 04/13/2006 | WO2006016370A3 Soluble fusion proteins comprising heterologous polypeptides |
| 04/13/2006 | WO2005012876A3 Methods of screening compositions for g protein-coupled receptor desensitization inhibitory activity |
| 04/13/2006 | US20060079451 Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same |
| 04/13/2006 | US20060078944 Methods and reagents relating to inflammation and apoptosis |
| 04/13/2006 | US20060078909 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 04/13/2006 | US20060078537 Mono-and dual chemokine/cytokine constructs |
| 04/12/2006 | CN1757739A Method of expressing heparinase and its special expression carrier |
| 04/12/2006 | CN1757413A Antibody inhibition body fluid immunity of using special integrated CD40CR(CD40 part) |
| 04/12/2006 | CN1250727C Pesticidal fusions |
| 04/12/2006 | CN1250722C Method for secretion and prodn. of protein |
| 04/12/2006 | CN1250721C Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 04/12/2006 | CN1250570C Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 04/11/2006 | US7026446 Chimeric antibody conjugate comprising an antigen binding region of a non-human antibody and an immunoglobulin constant region which comprises at least one CH domain or epitope thereof, where the constant region is not a naturally occurring FC fragment; useful as positive control reagents in immunoassays |
| 04/11/2006 | CA2358829C Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/11/2006 | CA2204375C Methods for the diagnosis of glaucoma |
| 04/06/2006 | WO2006036834A2 MODIFIED Fc MOLECULES |
| 04/06/2006 | WO2006035681A1 HLA-A11-RESTRICTED Tax ANTITUMOR EPITOPES |
| 04/06/2006 | WO2006013367A3 Chimeric heamaglutinin proteins and uses thereof |
| 04/06/2006 | US20060074234 Isolated mammalian membrane protein genes; related reagents |
| 04/06/2006 | US20060074230 Cartilage matrix protein fusion for use in prevention and treatment of diabetic retinopathy, edema, sepsis and blood disorders |
| 04/06/2006 | US20060073518 Method for selecting a candidate drug compound |
| 04/06/2006 | US20060073137 Humanised antibodies |
| 04/06/2006 | US20060073136 Humanised antibodies |
| 04/06/2006 | US20060073115 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis, inflamamatory disorders or infection by microorganisms |
| 04/05/2006 | EP1642980A1 Modified proteins and methods of their production |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642968A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642967A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642910A1 Rationally designed antibodies |
| 04/05/2006 | EP1642909A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 04/05/2006 | EP1642907A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1642906A2 Composition and methods for the diagnosis of tumours |
| 04/05/2006 | EP1641815A2 Uranium-chelating peptides and uses thereof |
| 04/05/2006 | EP0649435B1 Membrane-associated immunogens of mycobacteria |
| 04/05/2006 | CN1756768A Trimeric polypeptide construct to induce an enduring t cell response |
| 04/05/2006 | CN1754960A Fushion protein of melittin with gene mutant interleukin -2 |
| 04/05/2006 | CN1249439C Interleukin-6 receptor antagonist |
| 04/05/2006 | CN1249231C Actinia neurotoxin gene and its application |
| 04/05/2006 | CN1249229C Soluble T cell receptor |
| 04/05/2006 | CN1249088C Antitumour medicine containing recombinant bacterial toxin protein complex substance |
| 04/05/2006 | CN1249085C Immunogenic but non-amyloidogenic synthetic peptides homologous to beta amyloid for induction of immune response to beta amyloid and amyloid deposits |
| 04/05/2006 | CN1249079C Process for partitioning of proteins |
| 04/05/2006 | CA2479539A1 Recombinant adenylate cyclase / hiv-tat protein and therapeutic and diagnostic uses thereof |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022329 Using botulinum toxin |
| 03/30/2006 | WO2006032674A1 Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060068471 Soluble zcytor 11 cytokine receptors |
| 03/30/2006 | US20060068439 Ucp4 |
| 03/30/2006 | US20060067944 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/30/2006 | DE10347710B4 Rekombinante Impfstoffe und deren Verwendung Recombinant vaccines and their use |
| 03/30/2006 | CA2580208A1 Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| 03/29/2006 | EP1639111A2 Protein expression system |
| 03/29/2006 | EP1290197B1 Leader peptides for enhancing secretion of recombinant protein from a host cell |
| 03/29/2006 | EP1007554B1 Oil bodies and associated proteins as affinity matrices |
| 03/29/2006 | EP0961829B1 Fusion proteins for intracellular and intercellular transport and their uses |
| 03/29/2006 | EP0946715B1 Use of a modified protein c |
| 03/29/2006 | CN1752108A Soluble tumour necrosis factor receptor II- |
| 03/29/2006 | CN1247782C Actinia neurotoxin gene and its application |
| 03/29/2006 | CN1247781C Actinia neurotoxin gene and its application |
| 03/28/2006 | US7019197 fusion protein containing toxin domain and binding domain; corn/rice plants |
| 03/28/2006 | US7019125 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2006 | US7019111 Glycosylated ligand/receptor specificity exchangers specific for bacterial adhesion receptors |
| 03/28/2006 | US7018812 Membrane protein for use in treatment of arrhythmias, heart, kidney, diabetes, atherosclerosis, vision defects, rhinitis, respiratory and gastrointestinal disorders, allergies, inflammation, arthritis and inflammatory bowel disease |
| 03/28/2006 | US7018810 Chordin-like molecules and uses thereof |
| 03/23/2006 | WO2006030722A1 Amino acid sequence essential to neurospecific gene expression |
| 03/23/2006 | US20060063715 Multivalent antigen-binding proteins |
| 03/23/2006 | US20060062795 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062780 Myelin oligodendrocyte glycoprotein; 1st domain: deimmunized, autoreactive antigen specifically recognized by Ig receptors of autoreactive B-cells; 2nd domain: effector molecule capable of interacting with or activating NK-cells, T-cells, macrophages, monocytes or granulocytes; autoimmune diseases |
| 03/23/2006 | CA2823429A1 Sialidase catalytic domain proteins |
| 03/22/2006 | EP1637598A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 03/22/2006 | EP1637156A1 Systemic administration of osteogenic proteins in the treatment of metabolic bone diseases |
| 03/22/2006 | EP1636367A2 Method for producing a recombinant protein of interest and protein thus produced |
| 03/22/2006 | EP1636255A1 Modified oleosins |
| 03/22/2006 | EP1095147B1 Polyketides, their preparation, and materials for use therein |
| 03/22/2006 | EP1090123B1 Polyketides and their synthesis |
| 03/22/2006 | CN1749277A Heat shock protein 65-human SARS coronary virus epitope antigen recombinant fusion protein (HSP65SARS/3CL161-264) |
| 03/22/2006 | CN1749276A Heat shock protein 65-epithelial cell growth factor receptor 2 fusion protein (HSP65-HER2) |
| 03/22/2006 | CN1246337C Novel TNFR-Fc fusion protein |
| 03/21/2006 | US7015311 That binds to a neurturin polypeptide of given sequences that promotes survival of superior cervical ganglion cells or nodose ganglion cells; can be used to detect and monitor patient levels of neurturin |